Angiotensin IV analog comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-08-27. Where a claim depends on a specific study, the study is described rather than over-claimed.
Dihexa appears in scientific literature, patent documents, and commercial catalogs under several names, which can complicate searching and verification. The compound is frequently grouped with nootropics or research chemicals, terms that describe context of use rather than regulatory approval. Such labeling may imply benefits that have not been confirmed in controlled human studies. Readers encountering promotional descriptions should distinguish between preclinical observations and established medical facts. The absence of regulatory approval is a central feature of its current status.
Dihexa is a synthetic peptide-like compound studied in preclinical research for its reported effects on synaptic growth and cognitive measures in animal models. It is often described as an analog of angiotensin IV, a naturally occurring peptide fragment. The compound has not been approved as a medicine in any major jurisdiction. Most public information comes from laboratory studies, patents, and online vendor listings rather than from large clinical trials. Its scientific status therefore differs from that of an established pharmaceutical.
The compound originated from work on angiotensin IV, a peptide fragment of the renin-angiotensin system. Researchers modified angiotensin IV-related structures to produce molecules with altered stability and activity. Dihexa emerged from that effort and was reported to promote dendritic spine growth in cultured neurons. Some studies link its effects to hepatocyte growth factor signaling and the c-Met receptor, while other work points to insulin-regulated aminopeptidase. The precise primary target remains a subject of investigation, and findings may depend on cell type, assay conditions, and species.
In animal research, dihexa has been administered through several routes, and reports describe improved performance on spatial learning and memory tasks in rodents. These results are frequently cited in discussions of nootropic compounds. However, species differences, small sample sizes, and varied testing protocols limit how far the findings can be generalized. No large randomized controlled trials in humans have established efficacy or long-term safety. Claims about human cognitive enhancement therefore remain speculative, and the compound is best described as an experimental laboratory substance rather than a proven therapeutic or supplement.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic peptide analog | Derived from an angiotensin IV sequence. |
| Appearance | White to off-white powder | Typical for lyophilized research peptides. |
| Solubility | Soluble in dimethyl sulfoxide; sparingly in water | Exact aqueous solubility depends on salt form and purity. |
| Typical storage temperature | -20 °C or below | Desiccated and protected from light for long-term storage. |
| Common synonyms | Dihexa; N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide | Names vary in catalog listings. |
Human data for dihexa remain absent from peer-reviewed clinical literature. As a result, questions about absorption, distribution, metabolism, excretion, and long-term safety are unresolved. Discussions often appear in nootropic forums, where anecdotal reports cannot substitute for controlled trials. Researchers have called for more rigorous pharmacokinetic and toxicological studies before any clinical evaluation. Until such data exist, dihexa is best described as an investigational research compound rather than a proven intervention.
The proposed mechanism for dihexa centers on hepatocyte growth factor, or HGF, and its receptor c-Met. HGF signaling is involved in cell growth, survival, and synapse formation. Dihexa has been described as an HGF mimetic or modulator in preclinical literature. Whether it binds c-Met directly, increases HGF availability, or acts through another route remains uncertain. This mechanistic uncertainty is a recurring theme in reviews of the compound, and no single molecular model has been confirmed across independent laboratories.
Discussion of dihexa in online communities sometimes outpaces the scientific record. Anecdotal reports are difficult to verify and may not distinguish effects from placebo or expectation. The absence of approved human data means long-term risks remain unknown. Researchers continue to investigate related compounds and pathways. Open questions include whether animal findings translate to humans and which biological targets matter most. No consensus exists on these points. Current reviews emphasize the need for rigorous clinical research.
Most published work on dihexa consists of preclinical studies using cell cultures or rodents. Reports have described effects on synaptic connectivity and performance on cognitive tasks in some animal models. These findings are generally presented as preliminary and require independent replication. Study designs, doses, and outcome measures vary across experiments, which complicates direct comparison. No large controlled human trials have established efficacy or safety for any medical use. At present, the evidence base is limited.
Development of dihexa followed from studies on angiotensin IV analogs and their effects on learning and memory. Researchers sought compounds with improved metabolic stability and brain penetration compared with natural peptides. In preclinical reports, dihexa was associated with changes in synaptic connectivity and performance on spatial tasks. These findings generated interest in its potential as a cognitive research tool. The work remains largely preclinical, and independent replication has been limited.
Regulatory and commercial contexts differ from clinical medicine. Dihexa is not approved as a drug by major agencies, and no published human trials establish its safety or efficacy. It is often sold as a research chemical labeled for laboratory use only. Suppliers may provide certificates of analysis, but purity and identity depend on the specific batch. Legal status varies by country and may treat such compounds as unapproved substances for human consumption.
Dihexa is a synthetic peptidomimetic derived from angiotensin IV, a naturally occurring peptide fragment. It was created as a research compound to explore central nervous system signaling rather than as an approved therapeutic. Early work described it as a small, orally available molecule in rodent studies. Its structure combines tyrosine, isoleucine, and aminohexanoic acid components with a hexanoic acid cap. The compound is commonly referred to by the research code PNB-0408.
Chemically, dihexa belongs to a broader group of angiotensin IV analogs. Researchers have modified the natural peptide to alter stability, binding, or distribution. Such changes can affect how the molecule behaves in experiments. The parent peptide angiotensin IV is involved in various physiological processes, but the modified analog is not identical to it. Public summaries sometimes blur the distinction between the natural fragment and the synthetic research compound. This distinction matters when interpreting study results.
Dihexa is a synthetic peptide that has been examined in laboratory and animal research. Its design is based on angiotensin IV, a naturally occurring peptide fragment produced in the body. The short name dihexa appears in scientific papers and online discussions, while the full chemical name describes a modified peptide chain. It is not a vitamin, mineral, or plant-derived compound. Suppliers typically present it as a research chemical rather than an approved medicine.
== Sources == Dom Joseph Pothier, abbé bénédictin de Saint-Wandrille, Restaurateur du Chant grégorien, X.M.L., 1999-2009 (available at [1] [FR]), partially based on Dom Joseph Pothier, Abbé de Saint-Wandrille, et la restauration du chant grégorien, a biography by Dom Lucien David, O.S.B. (A.S.W).
Thomas Lectka is an American organic chemist, academic and researcher. He is Jean and Norman Scowe Professor of Chemistry and leads the Lectka Group at Johns Hopkins University. Lectka specializes in areas of catalysis in synthetic and mechanistic organic chemistry and has authored over 120 research publications. He has made contributions in the discovery of metal-catalyzed amide isomerization; the development of first practical method for the catalytic, asymmetric synthesis of beta-lactams; the synthesis of [C-F-C] fluoronium ions; and site-selective aliphatic fluorination.
Data published by the Home Office shows a 25% rise in reported incidents of religious hate crime over the past 12 months, largely against Muslims and Jews as a result of the Gaza war. 11 October Office for National Statistics figures show the UK economy grew by 0.2% during August, following two months of stagnation. Virginia McCullough, who murdered her parents in 2019 then lived in the family home alongside their bodies for four years, is sentenced to life imprisonment with a minimum term of 36 years. 12 October Alex Salmond, former first minister of Scotland, dies aged 69 in North Macedonia. A woman in her 20s is reported to have died after going overboard from a cruise ship near the Channel Islands in the early hours. 15 October Five people, including two children, are killed in a crash on the M6 in Cumbria. Former Chelsea boss Thomas Tuchel agrees to become the next England manager. 16 October Office for National Statistics figures show that UK inflation decreased unexpectedly to 1.7% in the year to September, its lowest level in over three years. A suspected gas explosion destroys three houses in Benwell, Newcastle, killing a seven-year-old boy and a man in his thirties, and hospitalising six other people. The University of Oxford rejects former Prime Minister of Pakistan Imran Khan's application to become chancellor. 17 October The National Gallery has banned liquids, such as baby formula and milk, from its premises following a number of attacks on artworks.
Recent nursing-ethics scholarship has connected harm reduction with trauma-informed care, critical pedagogy, and epistemic justice, arguing that safety, trust, collaboration, and recognition of lived experience are ethical features of the encounter rather than merely means of achieving better outcomes.
Sources: en.wikipedia.org
Figuratively translated as "Persevering through Hardship (for the sake of revenge)", the saying is derived from the Chinese chengyu of wòxīnchángdǎn (臥薪嘗膽), literally meaning "sleeping on sticks and tasting gall", that alludes to the perseverance of King Goujian of Yue (reigned 496–465 BC) in the war between Wu and Yue. For modern Japan, this ideology meant an increase in heavy industry and the strength of the armed forces, especially the navy, at the expense of individual wants and needs. The Triple Intervention had a profound effect on Japanese foreign relations, as Japanese diplomacy sought to avoid a reconstitution of a combination of European powers against Japan. It led directly to the Anglo-Japanese Alliance of 1902 which was explicitly intended to shield Japan from interference from other European great powers, and from Russia in particular.
The county borders, going anticlockwise from the west: Lancashire, Greater Manchester, Derbyshire, South Yorkshire and North Yorkshire. The terrain of the county mostly consists of the Pennines and its foothills which dominate the west of the county and gradually descend into the Vale of York and Humberhead Levels in the east. Geologically, it lies almost entirely on rocks of carboniferous age which form the inner Southern Pennine fringes in the west and the Yorkshire coalfield further eastwards. In the extreme east of the metropolitan county there are younger deposits of Magnesian Limestone. Areas in the west such as Bradford and Calderdale are dominated by the scenery of the eastern slopes of the South Pennines, dropping from upland in the west down to the east, and dissected by many steep-sided valleys while a small part of the northern Peak District extends into the south west of Kirklees. Large-scale industry, housing, public and commercial buildings of differing heights, transport routes and open countryside conjoin. The dense network of roads, canals and railways and urban development, confined by valleys creates dramatic interplay of views between settlements and the surrounding hillsides, as shaped the first urban-rural juxtapositions of David Hockney. Where most rural the land crops up in the such rhymes and folklore as On Ilkla Moor Baht 'at, date unknown, the early 19th century novels and poems of the Brontë family often in and around Haworth and long-running light comedy-drama Last of the Summer Wine in the 20th century.
=== Contaminant removal === Graphene oxide is non-toxic and biodegradable. Its surface is covered with epoxy, hydroxyl, and carboxyl groups that interact with cations and anions. It is soluble in water and forms stable colloid suspensions in other liquids because it is amphiphilic (able to mix with water or oil). Dispersed in liquids it shows excellent sorption capacities. It can remove copper, cobalt, cadmium, arsenate, and organic solvents.
Starmer announces the establishment of a "standing army" of specialist police officers to address the violence, and help bring it to an end. The FTSE 100 falls by more than 2%, its biggest drop since January, amid a global market selloff triggered by weaker-than-expected economic data from the US. 6 August 2024 United Kingdom riots: As the rioting enters its seventh day, the number of people arrested in relation to the disorder exceeds 400. The government announces an extra 567 prison places, while police chiefs announce an extra 2,200 riot trained officers will be deployed. Alder Hey Children's Hospital confirms that all the children treated as a result of the Southport stabbing have been discharged. The Senedd is recalled to elect a new First Minister of Wales, with Eluned Morgan nominated as the first woman to hold the post. Thames Water, Yorkshire Water and Northumbrian Water face fines of £168m fines by Ofwat over historic sewage spills. 7 August The Supreme Court rules that Shamima Begum will not be allowed to challenge the removal of her British citizenship. 2024 United Kingdom riots: UK police announce their largest mobilisation since the 2011 England riots, due to the threat of further violence targeting asylum seekers and immigrants, with 6,000 riot police on duty throughout the country and 2,000 in reserve as reinforcements. The first sentences for crimes committed during the riots are handed out to three men who took part in unrest in Southport and Liverpool. The three are sentenced to periods of between 20 months and three years in prison.
Except for placozoans, multicellular animals including humans have a variety of organ systems. These specific systems are widely studied in human anatomy. The functions of these organ systems often share significant overlap. For instance, the nervous and endocrine system both operate via a shared organ, the hypothalamus. For this reason, the two systems are combined and studied as the neuroendocrine system. The same is true for the musculoskeletal system because of the relationship between the muscular and skeletal systems.
Sources: en.wikipedia.org
Dihexa is a synthetic peptide-like compound studied in preclinical research. It is often described as an angiotensin IV analog, but it is not an approved medicine. Public information comes mainly from laboratory work and commercial listings.
No major regulatory agency has approved dihexa as a therapeutic product. Human safety and efficacy data are limited. Its sale as a research chemical does not constitute approval for medical use.
Some animal and cell studies report synaptic or cognitive effects, which has led to nootropic framing online. These findings are preliminary and have not been confirmed in robust human trials. The term nootropic is not a regulatory category.
Dihexa is a synthetic peptide-like compound studied primarily in preclinical models. It is often classified as an angiotensin IV analog and has been investigated for effects on neuronal connectivity. It is not an approved drug or dietary supplement.